< Back to search
Filter
1

Using Antibiotics Wisely - An Antimicrobial Stewardship Program

for
Multi-Drug Resistant Organisms, Late-Onset Sepsis, Neonatal,
Location: Edmonton
Sponsor: University of British Columbia

Sex: All

Age: 0

Code: NCT04388293

Recruiting

A Phase 2 Study of Radiotherapy-induced Immune Priming to Enhance Elranatamab (Elra) in Relapsed Refractory Multiple Myeloma (RRMM) With Extramedullary Disease (EMD) and Paramedullary Disease (PMD) "PRIME-EMD-PMD"

for
Phase 2, Radiotherapy-Induced Immune Priming, Elranatamab,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 0+

Code: NCT07382739

Phase2, Recruiting
New

A Study Evaluating the Safety, Pharmacokinetics, and Activity of Cevostamab in Participants With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Denver CO
Sponsor: Genentech, Inc.

Sex: All

Age: 18+

Code: NCT04910568

Phase1, Recruiting
New

Inobrodib, Pomalidomide and Dexamethasone Versus Standard Available Therapy in Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma Refractory, Multiple Myeloma in Relapse
Location: Miami FL
Sponsor: CellCentric Ltd.

Sex: All

Age: 18+

Code: NCT07772024

Phase3, Recruiting
New

A Pilot Study of Soursop Tea in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Multiple Myeloma (MM)

for
AML (Acute Myeloid Leukemia), Multiple Myeloma Refractory
Location: Camden NJ
Sponsor: Roger Strair

Sex: All

Age: 18+

Code: NCT07771803

Early_phase1, Recruiting

Interested in new multiple sclerosis trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
New

Systemic Anti-Cancer Therapy Dose Modifications for Individuals With Duffy Null Phenotype

for
Multiple Myeloma, Triple Negative Breast Cancer,
Location: Boston MA
Sponsor: Andrew Hantel, MD

Sex: All

Age: 18+

Code: NCT07341867

Phase1, Recruiting

In-Human CXCR4 Imaging of Hematologic and Solid Tumors Using [68Ga]-Pentixafor-PET

for
Non-Hodgkin Lymphoma, Multiple Myeloma, Histiocytic Neoplasms,
Location: New York NY
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT05093335

Early_phase1, Recruiting

Elranatamab in R/R Multiple Myeloma

for
Refractory Multiple Myeloma, Relapse Multiple Myeloma,
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18+

Code: NCT06138275

Phase2, Recruiting

Transcutaneous Spinal Cord Stimulation Home Study

for
Spinal Cord Injuries,
Location: Vancouver
Sponsor: Michael Berger

Sex: All

Age: 19 - 70

Code: NCT06838637

Recruiting

A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma

for
Multiple Myeloma, Myeloma, Myeloma Multiple
Location: Boston MA, New York NY, Hackensack NJ, Philadelphia PA,
Sponsor: K36 Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05651932

Phase1, Recruiting

[18F]F-DOPA Imaging in Patients With Autonomic Failure

for
Autonomic Failure, Pure Autonomic Failure, Parkinson Disease,
Location: Nashville TN
Sponsor: Daniel Claassen

Sex: All

Age: 18+

Code: NCT04246437

Phase1, Recruiting

Elotuzumab, Daratumumab, Iberdomide, and Dexamethasone for the Treatment of Relapsed Multiple Myeloma

for
Recurrent Multiple Myeloma
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT06785415

Phase1, Phase2, Recruiting

A Diagnostic Study of CD38-Targeted ImmunoPET of Myeloma

for
Multiple Myeloma
Location: Miami FL, Irvine CA
Sponsor: Hoag Memorial Hospital Presbyterian

Sex: All

Age: 21+

Code: NCT04814615

Phase2, Recruiting

The Ambient Light Multiple Myeloma Study

for
Multiple Myeloma
Location: New York NY
Sponsor: Icahn School of Medicine at Mount Sinai

Sex: All

Age: 21+

Code: NCT05737732

Recruiting

Total Marrow Irradiation & Autologous Stem Cell Transplantation for Relapsed or Refractory Myeloma

for
Multiple Myeloma
Location: Ottawa
Sponsor: Ottawa Hospital Research Institute

Sex: All

Age: 18 - 60

Code: NCT00800059

Phase1, Phase2, Recruiting

Isa-Rd for Frail and/or Much Older Patients With Newly Diagnosed Multiple Myeloma

for
Multiple Myeloma, Cancer
Location: Wilmington NC, Durham NC, Chapel Hill NC, Charlotte NC,
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT05145400

Phase2, Recruiting

A Trial to Test if TEV-56286 is Effective for Treatment of Participants With Multiple System Atrophy

for
Multiple System Atrophy
Location: Boston MA, New York NY, Pittsburgh PA, Tampa FL,
Sponsor: Teva Branded Pharmaceutical Products R&D LLC

Sex: All

Age: 30 - 70+

Code: NCT06568237

Phase2, Recruiting

A Multicentre, Non-Blinded Study Exploring Self-Administration of Chemotherapy in the Home Environment

for
Myeloma, Myeloma Multiple
Location: Edmonton, Calgary
Sponsor: AHS Cancer Control Alberta

Sex: All

Age: 18+

Code: NCT04268199

Phase2, Recruiting

Development of a Research Infrastructure for Understanding and Addressing Multiple Myeloma Disparities

for
Multiple Myeloma
Location: Sacramento CA
Sponsor: University of California, Davis

Sex: All

Age: 21+

Code: NCT04314752

Recruiting

Oral Adherence in Hematological Oncology Agents and Impact on Comorbid Therapy Adherence

for
Chronic Myeloid Leukemia, Chronic Lymphocytic Leukemia,
Location: Nashville TN
Sponsor: University of Tennessee

Sex: All

Age: 18+

Code: NCT04663100

Recruiting